Huzhou Zhanwang Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LEUCOVORIN CALCIUM, with a corresponding US DMF Number 38878.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 26, 2024, and payment made on June 10, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II